Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma

NCT02029573 is registered in ClinicalTrials.gov with King Fahad Medical City as lead sponsor.

NCT NCT02029573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02029573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma
Lead sponsor
King Fahad Medical City
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2014
Completion date
December 31, 2016
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme